Healthcare -
Biotechnology - NASDAQ - US
$ 279.01
0.667 %
$ 36 B
Market Cap
-106.09
P/E
ALNY - SHORT-TERM DEBT
Short-term Debt ALNY - Alnylam Pharmaceuticals, Inc.
96.5 M
LAST VALUE
11.50%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR